GlassScriptPhysician profile
Howard C Harper
NPI 1184654592
$1,398.22
in general payments reported to CMS, 2019-2025
28 companies · $74.59 in 2025
The $74.59 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $52.65 · 2021: $251 · 2022: $397 · 2023: $115 · 2024: $131 · 2025: $74.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $303.51 | 2022 | |
| W. L. Gore & Associates, INC. | $279.48 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Intuitive Surgical, INC. | $164.40 | 2020-2023 | Da Vinci Surgical System |
| Angiodynamics, INC. | $60.12 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Bard Peripheral Vascular, INC. | $50.33 | 2019-2021 | |
| Boston Scientific Corporation | $39.25 | 2021-2022 | |
| Artivion, INC. | $38.27 | 2022-2024 | Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Acera Surgical, INC. | $37.90 | 2019-2024 | Restrata Wound Matrix |
| Tela Bio, INC. | $34.85 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Phathom Pharmaceuticals, INC. | $34.24 | 2025 | Voquezna |
| Smith+Nephew, INC. | $30.78 | 2019-2021 | |
| Ethicon US, LLC | $29.47 | 2021-2023 | Echelon; Endopath |
| Elucent Medical | $26.37 | 2025 | |
| Janssen Pharmaceuticals, INC | $26.35 | 2019-2020 | |
| Integra Lifesciences Corporation | $24.59 | 2024 | Integra, Surgimend, Omnigraft |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $23.99 | 2021 | |
| Medtronic Vascular, INC. | $23.37 | 2019 | |
| Kerecis Limited | $19.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Cardinal Health 414 LLC | $18.42 | 2019 | |
| Innocoll Pharmaceuticals Limited | $17.02 | 2021 | |
| Polynovo North America LLC | $16.11 | 2022 | |
| Cook Medical LLC | $15.92 | 2024 | Zenith Spiral-Z |
| Medtronic, INC. | $15.72 | 2023 | Signia |
| Exact Sciences Corporation | $15.72 | 2024 | Cologuard Collection Kit |
| Lsi Solutions INC | $14.62 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.00 | 2021 | |
| Focal Therapeutics, INC. | $12.86 | 2021 | |
| Aesculap, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.